by Monash University Apoptotic MSC (red) is engulfed by a macrophage (green). Credit: Professor Tracy Heng The therapeutic benefit to patients receiving mesenchymal stromal cell (MSC) therapy is not because the injected cells remain viable, but because of cell death, researchers at the Monash Biomedicine Discovery Institute (BDI) have found. In recent years, significant efforts...
